Zentiva, a.s.'s latest marketcap:
As of 07/05/2025, Zentiva, a.s.'s market capitalization has reached $57.23 M. According to our data, Zentiva, a.s. is the 28751th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 57.23 M |
| Revenue (ttm) | 42.59 M |
| Net Income (ttm) | 2.7 M |
| Shares Out | 1.62 M |
| EPS (ttm) | 1.66 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | n/a |
Zentiva, a.s.'s yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | €57.23 M | -3.23% | 28751 |
| 12/11/2024 | €50.23 M | 3.33% | 27736 |
| 12/20/2023 | €48.61 M | 20% | 27291 |
| 11/24/2022 | €40.5 M | -17.76% | 27846 |
| 12/17/2021 | €49.25 M | -66.22% | 26858 |
| 12/09/2020 | €145.82 M | -40% | 17391 |
| 12/19/2019 | €243.03 M | -40% | 13248 |
| 12/11/2018 | €405.05 M | -28.57% | 9503 |
| 12/12/2017 | €567.07 M | 40% | 8931 |
| 12/23/2016 | €405.05 M | 31.58% | 10013 |
Company Profile
About Zentiva, a.s.
Zentiva, a.s. is a leading pharmaceutical company specializing in the development, manufacturing, and sale of generic medicinal products. Primarily serving the primary care sector, the company operates in Slovakia, the Czech Republic, and internationally.
Product Portfolio
The company offers a diverse range of prescription medicines, including:
- Lipid-lowering agents
- Hypotensives
- Sympatholytics
- Prokinetics
- Vitamins
- Antipyretics
- Beta-blockers
- Otorhinolaryngological products
- Antidiabetics
- Antihistamines
With 56 pharmaceutical forms available in Slovakia, Zentiva ensures a broad and accessible healthcare solution.
Business Activities
In addition to pharmaceutical sales, Zentiva engages in:
- Production of pharmaceuticals and chemical products
- Wholesale distribution of medical supplies
Corporate Background
Originally established as Slovakofarma, a.s., the company rebranded to Zentiva, a.s. in 2003. Founded in 1992 and headquartered in Bratislava, Slovakia, Zentiva operates as a subsidiary of ZENTIVA PHARMA GMBH.
Frequently Asked Questions
-
What is Zentiva, a.s.'s (BSSE-1SKF401E) current market cap?As of 07/05/2025, Zentiva, a.s. (including the parent company, if applicable) has an estimated market capitalization of $57.23 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Zentiva, a.s. (BSSE-1SKF401E) rank globally by market cap?Zentiva, a.s. global market capitalization ranking is approximately 28751 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.